SCHEMBL4510286

SCHEMBL4510286

COc1ccc2c(NC(=O)/C=C/c3ccccc3)c(C(C)=O)oc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 5/20 0.54
MMP2 P08253 5/20 0.54
MMP9 P14780 5/20 0.54
EGFR P00533 2/20 0.54
KMT2A Q03164 4/20 0.51
LMNA P02545 2/20 0.51
MEN1 O00255 2/20 0.51
PKM P14618 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
CA12 O43570 1/20 0.47
CA9 Q16790 1/20 0.47
TRPA1 O75762 1/20 0.47
MAPT P10636 1/20 0.47
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
MAOA P21397 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4510297 1.00 MMP1 (0.54) MMP1MMP2MMP9EGFRKMT2A
SCHEMBL4494671 0.85 KDM4E (0.49) SMN1; SMN2NPC1RAB9ACA12CA9
SCHEMBL4494676 0.85 KDM4E (0.49) SMN1; SMN2NPC1RAB9ACA12CA9
SCHEMBL4509875 0.79 SMN1; SMN2 (0.60) MMP1MMP2MMP9EGFRKMT2A
SCHEMBL4509868 0.79 SMN1; SMN2 (0.60) MMP1MMP2MMP9EGFRKMT2A
SCHEMBL13699798 0.78 CA12 (0.55) KMT2AMEN1PKMSMN1; SMN2NPC1
SCHEMBL4492607 0.78 ALDH1A1 (0.54) MMP1MMP2MMP9EGFRKMT2A
SCHEMBL4492601 0.78 ALDH1A1 (0.54) MMP1MMP2MMP9EGFRKMT2A
SCHEMBL4503448 0.77 MMP1 (0.55) MMP1MMP2MMP9EGFRKMT2A
SCHEMBL4503457 0.77 MMP1 (0.55) MMP1MMP2MMP9EGFRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638540-B2 Benzofuran compound and medicinal composition containing the same THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) 2009-12-29 US disclosed
US-7638540-B2 Benzofuran compound and medicinal composition containing the same THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) 2009-12-29 US disclosed
US-7638540-B2 Benzofuran compound and medicinal composition containing the same THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) 2009-12-29 US disclosed
US-20060194851-A1 Benzofuran compound and medicinal composition containing the same NEW INDUSTRY RESEARCH ORGANIZATION, THE (JP) 2006-08-31 US disclosed
EP-1627873-A1 BENZOFURAN COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME The New Industry Research Organization (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194851-A1 Benzofuran compound and medicinal composition containing the same LTB4R2, LTC4S, LTB4R MMP1 1487/4885MMP2 2172/4885MMP9 1537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.